West Pharmaceutical Services, Inc. (WST)
USD 325.32
(-2.67%)
USD 325.32
(-2.67%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.94 Billion | 2.88 Billion | 2.83 Billion | 2.14 Billion | 1.83 Billion | 1.71 Billion |
| Cost of Revenue | 1.82 Billion | 1.75 Billion | 1.65 Billion | 1.37 Billion | 1.23 Billion | 1.17 Billion |
| Gross Profit | 1.12 Billion | 1.13 Billion | 1.17 Billion | 767.8 Million | 605.7 Million | 545.4 Million |
| Operating Expenses | 454 Million | 402.2 Million | 423.5 Million | 360.9 Million | 311.6 Million | 303.2 Million |
| Selling, General and Administrative Expenses | 353.4 Million | 316.9 Million | 362.8 Million | 302 Million | 272.7 Million | 262.9 Million |
| Research and Development Expenses | 68.4 Million | 58.5 Million | 52.8 Million | 46.9 Million | 38.9 Million | 40.3 Million |
| Other Expenses | 31.4 Million | 26.8 Million | 7.9 Million | 12 Million | 2.4 Million | 4.8 Million |
| Cost and Expenses | 2.27 Billion | 2.15 Billion | 2.07 Billion | 1.74 Billion | 1.54 Billion | 1.47 Billion |
| Operating Income | 676 Million | 734 Million | 752.3 Million | 406.9 Million | 296.6 Million | 240.3 Million |
| Interest Expense | 9 Million | 7.9 Million | 7.2 Million | 6.8 Million | 4.7 Million | 6.3 Million |
| Income Tax Expense | 122.3 Million | 114.7 Million | 107.2 Million | 72.5 Million | 59 Million | 41.4 Million |
| Earnings before Tax | 698 Million | 679.9 Million | 748.9 Million | 401.3 Million | 291.8 Million | 240.7 Million |
| Net Income | 593.4 Million | 585.9 Million | 661.8 Million | 346.2 Million | 241.7 Million | 206.9 Million |
| Earnings Per Share Basic | 7.99 | 7.88 | 8.90 | 4.68 | 3.27 | 2.80 |
| Earnings Per Share Diluted | 7.88 | 7.73 | 8.67 | 4.57 | 3.21 | 2.74 |
| Weighted Average Shares Outstanding | 74.3 Million | 74.4 Million | 74.4 Million | 73.9 Million | 74 Million | 73.9 Million |
| Weighted Average Shares Outstanding (Diluted) | 75.3 Million | 75.8 Million | 76.3 Million | 75.8 Million | 75.4 Million | 75.4 Million |
| Gross Margin | 0.38 | 0.39 | 0.42 | 0.36 | 0.33 | 0.32 |
| EBIT Margin | 0.29 | 0.30 | 0.31 | 0.24 | 0.22 | 0.14 |
| Profit Margin | 0.20 | 0.20 | 0.23 | 0.16 | 0.13 | 0.12 |
| EBITDA | 847.8 Million | 887.9 Million | 895.2 Million | 531.7 Million | 399.4 Million | 355.3 Million |
| Earnings Before Tax Margin | 0.23 | 0.25 | 0.27 | 0.19 | 0.16 | 0.14 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 746.9 Million | 702 Million | 695.4 Million | 2.94 Billion | 732 Million | 747.4 Million |
| Cost of Revenue | 482.2 Million | 470.7 Million | 465.2 Million | 1.82 Billion | 453.8 Million | 459.1 Million |
| Gross Profit | 264.7 Million | 231.3 Million | 230.2 Million | 1.12 Billion | 278.2 Million | 288.3 Million |
| Operating Expenses | 99 Million | 100.5 Million | 107.4 Million | 421.8 Million | 108.4 Million | 105.4 Million |
| Selling, General and Administrative Expenses | 83.5 Million | 83 Million | 86.7 Million | - | 90 Million | 89 Million |
| Research and Development Expenses | 15.5 Million | 17.5 Million | 17.6 Million | - | 18.4 Million | 16.4 Million |
| Other Expenses | -4.4 Million | 3.3 Million | -3.1 Million | 3 Million | -1.1 Million | -1.8 Million |
| Cost and Expenses | 581.2 Million | 571.2 Million | 572.6 Million | 2.24 Billion | 562.2 Million | 564.5 Million |
| Operating Income | 161.3 Million | 130.8 Million | 122.8 Million | 676 Million | 160.9 Million | 177.3 Million |
| Interest Expense | 700 Thousand | 1.5 Million | 1.6 Million | 9 Million | 1.2 Million | 2.9 Million |
| Income Tax Expense | 32.4 Million | 21.9 Million | 16.39 Million | 122.3 Million | 34.5 Million | 29.4 Million |
| Earnings before Tax | 164.5 Million | 128.69 Million | 127.4 Million | 698 Million | 168.2 Million | 187 Million |
| Net Income | 136 Million | 111.3 Million | 115.3 Million | 593.4 Million | 137 Million | 161.3 Million |
| Earnings Per Share Basic | 1.87 | 1.52 | 1.57 | - | 1.85 | 2.17 |
| Earnings Per Share Diluted | 1.85 | 1.51 | 1.55 | - | 1.83 | 2.14 |
| Weighted Average Shares Outstanding | 72.8 Million | 73 Million | 73.5 Million | 74.3 Million | 74.1 Million | 74.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 73.4 Million | 73.7 Million | 74.3 Million | 75.3 Million | 75 Million | 75.3 Million |
| Gross Margin | 0.35 | 0.33 | 0.33 | 0.38 | 0.38 | 0.39 |
| EBIT Margin | 0.28 | 0.24 | 0.23 | - | 0.29 | 0.29 |
| Profit Margin | 0.18 | 0.16 | 0.17 | 0.20 | 0.19 | 0.22 |
| EBITDA | 205.4 Million | 169.7 Million | 158.4 Million | - | 214 Million | 218.6 Million |
| Earnings Before Tax Margin | 0.22 | 0.19 | 0.18 | 0.23 | 0.22 | 0.24 |
HIHI
0301
6780
DEEPENR
MONTECARLO
CWX